Dr Matthew A. Cooper is Founder and Managing Director of Cambridge Medical Innovations and Co-Founder and Chief Scientific Officer of Akubio. Dr Cooper is consulted widely for biosensor, biotechnology, and pharmaceutical companies in the UK, Europe, and the United States. He is a review panel member for BBSRC, EPSRC, US NIH, US NIAID, and Science Foundation Ireland and a Fellow of the Royal Society of Medicine.